Clincosm LogoSign in Get a demo

substance withdrawal syndrome

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Abuse and Addiction in ICU

Active, not recruiting
  • Substance Withdrawal Syndrome
  • AUDIT-C
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 18, 2021

Substance Withdrawal Syndrome Trial in Chengdu (Electro-Acupuncture)

Recruiting
  • Substance Withdrawal Syndrome
  • Electro-Acupuncture
  • Chengdu, Sichuan, China
    Affliated Hospital of Chengdu University of Traditional Chinese
Jun 7, 2021

Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in

Completed
Has Results
  • Substance Withdrawal Syndrome
  • Montréal, Quebec, Canada
    McGill University Health Centre
Jan 8, 2021

Substance Withdrawal Syndrome Trial in Minneapolis (Olanzapine, Clonidine)

Completed
Has Results
  • Substance Withdrawal Syndrome
  • Minneapolis, Minnesota
    Hennepin County Medical Center
Jun 20, 2019

Substance Withdrawal Syndrome Trial in Baltimore, Burlington (Abstinence from e-cigarettes)

Completed
  • Substance Withdrawal Syndrome
  • Abstinence from e-cigarettes
  • Baltimore, Maryland
  • +1 more
Nov 19, 2018

Delirium, Psychomotor Agitation, Substance Withdrawal Syndrome Trial in Ede, Deventer (Transdermal nicotine patch, Cutaneous

Completed
Has Results
  • Delirium
  • +3 more
  • Transdermal nicotine patch
  • Cutaneous patch, containing no active substances
  • Ede, Gelderland, Netherlands
  • +1 more
Mar 3, 2018

Opioid Withdrawal Symptoms in Critically Ill Patients

Completed
  • Substance Withdrawal Syndrome
  • Critical Illness
  • Ratchathewi, Bangkok, Thailand
    Faculty of Pharmacy, Mahidol University
Oct 8, 2018

Substance Withdrawal Syndrome, Opiate Addiction, Opiate Dependence Trial in Overland Park (lofexidine administration in subjects

Completed
  • Substance Withdrawal Syndrome
  • +2 more
  • lofexidine administration in subjects seeking buprenorphine dose reduction
  • Overland Park, Kansas
    (unnamed)
Oct 24, 2017

Substance Withdrawal Syndrome Trial in Stanford (Ondansetron and Placebo crossover)

Completed
Has Results
  • Substance Withdrawal Syndrome
  • Ondansetron and Placebo crossover
  • Stanford, California
    Stanford University School of Medicine
May 9, 2017

Substance Withdrawal Syndrome Trial in Lexington (Tramadol, Placebo)

Completed
Has Results
  • Substance Withdrawal Syndrome
  • Lexington, Kentucky
    University of Kentucky
Mar 7, 2017

Cocaine-Related Disorders, Substance Withdrawal Syndrome, Substance-Related Disorders Trial in Minneapolis (Cocaine)

Completed
  • Cocaine-Related Disorders
  • +2 more
  • Cocaine
  • Minneapolis, Minnesota
    University of Minnesota
Jan 11, 2017

Heroin Dependence, Morphine Dependence, Substance Withdrawal Syndrome Trial in United States (Buprenorphine/naloxone)

Completed
  • Heroin Dependence
  • +2 more
  • Rancho Mirage, California
  • +5 more
Jan 11, 2017

Heroin Dependence, Morphine Dependence, Substance Withdrawal Syndrome Trial in United States (Buprenorphine/naloxone)

Completed
  • Heroin Dependence
  • +2 more
  • Berkeley, California
  • +6 more
Jan 11, 2017

Substance Withdrawal Syndrome Trial in Pittsburgh (Melatonin, Matched Placebo)

Completed
  • Substance Withdrawal Syndrome
  • Melatonin
  • Matched Placebo
  • Pittsburgh, Pennsylvania
    Salvation Army Harbor Light Center
Aug 4, 2016

Risk Screening and Decrease of Alcohol Withdrawal in ENT

Completed
  • Substance Withdrawal Syndrome
  • Process evaluation
  • Basel, Switzerland
    University Hospital Basel
Jul 11, 2016

Elderly, Drug Therapy Syndrome, Substance-Related Disorders Trial (Immediate intervention)

Completed
  • Elderly
  • +3 more
  • Immediate intervention
  • (no location specified)
Mar 16, 2016

Opioids Withdrawal Syndrome in Critically Ill

Completed
  • Substance Withdrawal Syndrome
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur
Feb 17, 2016

Opioid-Related Disorders, Substance Withdrawal Syndrome Trial in Minneapolis (Dynorphin 1 - 13)

Completed
  • Opioid-Related Disorders
  • Substance Withdrawal Syndrome
  • Dynorphin 1 - 13
  • Minneapolis, Minnesota
    U of Minnesota School of Medicine
May 26, 2015

Substance Withdrawal Syndrome, Nicotine Dependence Trial in Toronto (Nicotine, Placebo)

Completed
  • Substance Withdrawal Syndrome
  • Nicotine Dependence
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health, BACDRL Lab
May 4, 2015

Substance Withdrawal Syndrome Trial in Durham, Raleigh (dehydroepiandrosterone (DHEA), pregnenolone, Placebo)

Completed
  • Substance Withdrawal Syndrome
  • dehydroepiandrosterone (DHEA)
  • +2 more
  • Durham, North Carolina
  • +1 more
Sep 14, 2012

Substance Withdrawal Syndrome, Drug Withdrawal Symptoms, Anxiety Trial in Halifax (Therapeutic Massage, Relaxation Control)

Completed
  • Substance Withdrawal Syndrome
  • +2 more
  • Therapeutic Massage
  • Relaxation Control
  • Halifax, Nova Scotia, Canada
    Addiction Prevention and Treatment Services; Capital District
Oct 8, 2009

Substance Withdrawal Syndrome Trial in Helsinki (valproate)

Completed
  • Substance Withdrawal Syndrome
  • Helsinki, Uusimaa, Finland
    Helsinki University Central Hospital, Department of Psychiatry,
Oct 16, 2008

Cannabis Dependence, Substance Withdrawal Syndrome Trial in Fairfield (Lithium carbonate)

Completed
  • Cannabis Dependence
  • Substance Withdrawal Syndrome
  • Lithium carbonate
  • Fairfield, New South Wales, Australia
    Corella Drug Treatment Service
Sep 26, 2007

Opiate Dependence, Drug Dependence, Substance Withdrawal Syndrome Trial in Kristiansand (Buprenorphine, Valproate)

Completed
  • Opiate Dependence
  • +2 more
  • Kristiansand, Vest-Agder, Norway
    Sorlandet Hospital HF, Addiction Unit (ARA)
Aug 22, 2006